JENSEN BIOCONSULT ApS: Financial statements 2023
CVR: 35670491
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
JENSEN BIOCONSULT ApS (CVR 35670491) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -1,096 and a net result of DKK -20,094 compared with DKK -15,280 the year before. Equity in the 2023 report amounted to DKK -21,196.
- Gross Profit
- DKK -1,096
- Profit/Loss
- DKK -20,094
- Equity
- DKK -21,196
- Total Assets
- DKK 240,800
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -1 t. | -20 t. | -21 t. | - |
| 2022 | - | -5 t. | -15 t. | -1 t. | - |
| 2021 | - | -6 t. | -14 t. | 14 t. | - |
| 2020 | - | -7 t. | -15 t. | 29 t. | - |
| 2019 | - | 6 t. | 5 t. | 43 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
JENSEN BIOCONSULT ApS has published its annual report for 2022. Gross profit came to DKK -5,440, and the net result was DKK -15,280.
About JENSEN BIOCONSULT ApS
JENSEN BIOCONSULT ApS is a Danish company of the type Anpartsselskab based in Stenløse, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named JENSEN BIOCONSULT IVS. The management consists of Simon Skjøde Jensen. The company is owned by Simon Skjøde Jensen. The company has 0 employees (2014). In 2025, the company reported a gross profit of DKK -4,120 and a net result of DKK -32,288 compared with DKK -24,690 the year before. Equity in the 2025 report amounted to DKK -71,674.